Publications

  1. Chakraborty R, Novak AJ , Ansell SM , Muchtar E , Kapoor P , Hayman SR , Dispenzieri A , Buadi FK , Lacy MQ , King RL , Gertz MA . First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis. Blood 2016 Jun 9; 127 (23):2936-8 Epub 2016 Mar 31
    View PubMed
  2. Ravindran A , Gonsalves WI , Hashmi SK , Kapoor P , Marshall AL , Siddiqui MA , Go RS . Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely? Leuk Lymphoma 2016 Jun 9; 1-2 Epub 2016 June 09
    View PubMed
  3. Kourelis TV , Buadi FK , Kumar SK , Gertz MA , Lacy MQ , Dingli D , Go RS , Kapoor P , Lust JA , Hayman SR , Hwa Y , Rajkumar SV , Zeldenrust SR , Russell SJ , Lin Y, Leung N , Kyle RA , Gonsalves WI , Dispenzieri A . Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience. Am J Hematol 2016 Jun; 91 (6):585-9 Epub 2016 Apr 13
    View PubMed
  4. Higgins LS, Go RS , Dingli D , Kumar SK , Rajkumar SV, Dispenzieri A , Buadi FK , Lacy MQ , Lust JA , Kapoor P , Leung N , Lin Y, Kourelis TV , Gertz MA , Kyle RA , Gonsalves WI . Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies. Clin Lymphoma Myeloma Leuk 2016 May 5 Epub 2016 May 05
    View PubMed
  5. Kourelis TV , Buadi FK , Gertz MA , Lacy MQ , Kumar SK , Kapoor P , Go RS , Lust JA , Hayman SR , Rajkumar V , Zeldenrust SR , Russell SJ , Dingli D , Lin Y , Leung N , Hwa YL , Gonsalves W , Kyle RA , Dispenzieri A . Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment. Leukemia 2016 May; 30 (5):1079-85 Epub 2015 Dec 16
    View PubMed
  6. Mullikin TC, Rajkumar SV , Dispenzieri A , Buadi FK , Lacy MQ , Lin Y, Dingli D , Go RS , Hayman SR , Zeldenrust SR , Russell SJ , Lust JA , Leung N , Kapoor P , Kyle RA , Gertz MA , Kumar SK . Clinical characteristics and outcomes in biclonal gammopathies. Am J Hematol 2016 May; 91 (5):473-5 Epub 2016 Apr 06
    View PubMed
  7. Gonsalves WI , Timm MM, Rajkumar SV , Morice WG , Dispenzieri A , Buadi FK , Lacy MQ , Dingli D , Leung N , Kapoor P , Kyle RA , Gertz MA , Kumar SK . The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma. Leuk Res 2016 May; 44:32-9 Epub 2016 Mar 10
    View PubMed
  8. Gonsalves WI , Rajkumar SV , Gertz MA , Dispenzieri A , Lacy MQ , Buadi FK , Dingli D , Go RS , Leung N , Kapoor P , Hayman SR , Lust JA , Russell SJ , Zeldenrust SR , Hwa YL , Kourelis TV , Kyle RA , Kumar SK . Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy. Bone Marrow Transplant 2016 Apr 11 [Epub ahead of print]
    View PubMed
  9. Nathwani N , Larsen JT , Kapoor P . Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents. Curr Hematol Malig Rep 2016 Apr; 11 (2):127-36
    View PubMed
  10. Kaufman GP , Gertz MA , Dispenzieri A , Lacy MQ , Buadi FK , Dingli D , Hayman SR , Kapoor P , Lust JA , Russell S , Go RS , Hwa YL , Kyle RA , Rajkumar SV , Kumar SK . Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma. Leukemia 2016 Mar; 30 (3):633-9 Epub 2015 Oct 21
    View PubMed
  11. Kapoor P , Paludo J , Ansell SM . Waldenstrom Macroglobulinemia: Familial Predisposition and the Role of Genomics in Prognosis and Treatment Selection. Curr Treat Options Oncol 2016 Mar; 17 (3):16
    View PubMed
  12. Cordes S, Gertz MA, Buadi FK, Lin Y, Lacy MQ, Kapoor P, Kumar SK, McCurdy A, Dispenzieri A, Dingli D, Hayman SR, Hogan WJ, Pruthi RK. Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency. Blood Coagul Fibrinolysis 2016 Jan; 27 (1):101-8
    View PubMed
  13. Binder M , Rajkumar SV , Ketterling RP , Dispenzieri A , Lacy MQ , Gertz MA , Buadi FK , Hayman SR , Hwa YL , Zeldenrust SR , Lust JA , Russell SJ , Leung N , Kapoor P , Go RS , Gonsalves WI , Kyle RA , Kumar SK . Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma. Blood Cancer J 2016; 6:e401 Epub 2016 Mar 11
    View PubMed
  14. Leung N, Kumar SK, Glavey SV, Dispenzieri A, Lacy MQ, Buadi FK, Hayman SR, Dingli D, Kapoor P, Zeldenrust SR, Russell SJ, Lust JA, Hogan WJ, Rajkumar SV, Gastineau DA, Kourelis TV, Lin Y, Gonsalves WI, Go RS, Gertz MA. The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantation. Nephrol Dial Transplant. 2015 Nov 30.
    View PubMed
  15. Majithia N , Vincent Rajkumar S , Lacy MQ , Buadi FK , Dispenzieri A , Gertz MA , Hayman SR , Dingli D , Kapoor P , Hwa L , Lust JA , Russell SJ , Go RS , Kyle RA , Kumar SK . Outcomes of primary refractory multiple myeloma and the impact of novel therapies. Am J Hematol 2015 Nov; 90 (11):981-5 Epub 2015 Oct 06
    View PubMed
  16. Alhaj Moustafa M , Rajkumar SV , Dispenzieri A , Gertz MA , Lacy MQ , Buadi FK , Hwa YL , Dingli D , Kapoor P , Hayman SR , Lust JA , Kyle RA , Kumar SK . Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy. Leukemia 2015 Oct; 29 (10):2033-8 Epub 2015 May 12
    View PubMed
  17. Chakraborty R, Kapoor P , Ansell SM , Gertz MA . Ibrutinib for the treatment of Waldenstrom macroglobulinemia. Expert Rev Hematol 2015 Oct; 8 (5):569-79 Epub 2015 July 02
    View PubMed
  18. Binder M, Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Buadi FK, Dingli D, Hayman SR, Lust JA, Kapoor P, Lin Y, Go RS, Hwa YL, Kyle RA, Kumar SK. Predictors of early response to initial therapy in patients with newly diagnosed symptomatic multiple myeloma. Am J Hematol 2015 Oct; 90 (10):888-91 Epub 2015 Sept 01
    View PubMed
  19. Kapoor P , Paludo J , Vallumsetla N , Greipp PR . Waldenstrom macroglobulinemia: What a hematologist needs to know. Blood Rev 2015 Sep; 29 (5):301-19 Epub 2015 Mar 24
    View PubMed
  20. Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, Kyle RA, Mikhael JR, Roy V, Leung N, Grogan M, Kapoor P, Lust JA, Dingli D, Go RS, Hwa YL, Hayman SR, Fonseca R, Ailawadhi S, Bergsagel PL, Chanan-Khan A, Rajkumar SV, Russell SJ, Stewart K, Zeldenrust SR, Gertz MA. Zeldenrust SR, Gertz MA. Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement. Mayo Clin Proc. 2015 Aug; 90(8):1054-81.
    View PubMed
  21. Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, Rajkumar SV, Kyle RA, Jaffe A. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T. Am J Hematol. 2015 Jun; 90(6):524-8. Epub 2015 Apr 02.
    View PubMed
  22. Mir MA , Kapoor P , Kumar S , Pandey S , Dispenzieri A , Lacy MQ , Dingli D , Hogan W , Buadi F , Hayman S , Gandhi M , Gertz MA . Trends and outcomes in allogeneic hematopoietic stem cell transplant for multiple myeloma at Mayo Clinic. Clin Lymphoma Myeloma Leuk 2015 Jun; 15 (6):349-357.e2 Epub 2015 Apr 02
    View PubMed
  23. Bhutani G, Nasr SH, Said SM, Sethi S, Fervenza FC, Morice WG, Kurtin PJ, Buadi FK, Dingli D, Dispenzieri A, Gertz MA, Lacy MQ, Kapoor P, Kumar S, Kyle RA, Rajkumar SV, Leung N. Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits. Mayo Clin Proc. 2015 May; 90(5):587-96.
    View PubMed
  24. Kaufman GP, Dispenzieri A, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Kapoor P, Go RS, Zeldenrust SR, Kyle RA, Rajkumar SV, Kumar SK. Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis. Am J Hematol. 2015 Mar; 90(3):181-6. Epub 2015 Jan 16.
    View PubMed
  25. Gonsalves WI , Leung N , Rajkumar SV , Dispenzieri A , Lacy MQ , Hayman SR , Buadi FK , Dingli D , Kapoor P , Go RS , Lin Y , Russell SJ , Lust JA , Zeldenrust S , Kyle RA , Gertz MA , Kumar SK . Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Blood Cancer J 2015; 5:e296 Epub 2015 Mar 20
    View PubMed
  26. Warsame R , Kumar SK , Gertz MA , Lacy MQ , Buadi FK , Hayman SR , Leung N , Dingli D , Lust JA , Ketterling RP , Lin Y , Russell S , Hwa L , Kapoor P , Go RS , Zeldenrust SR , Kyle RA , Rajkumar SV , Dispenzieri A . Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death. Blood Cancer J 2015; 5:e310 Epub 2015 May 01
    View PubMed
  27. Chakraborty R, Ansell SA, Kapoor P, Gertz MA. Phase II clinical trials for Waldenstrom's macroglobulinemia. Expert Opinion on Orphan Drugs. 2015; 3(5):537-47.
  28. Chakraborty R, Kapoor P , Ansell SM , Gertz MA . Emerging therapeutic options for Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma. Expert Rev Anticancer Ther 2015; 15 (10):1143-56 Epub 2015 July 21
    View PubMed
  29. Kumar SK , LaPlant B , Roy V , Reeder CB , Lacy MQ , Gertz MA , Laumann K , Thompson MA , Witzig TE , Buadi FK , Rivera CE , Mikhael JR , Bergsagel PL , Kapoor P , Hwa L , Fonseca R , Stewart AK , Chanan-Khan A , Rajkumar SV , Dispenzieri A . Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib. Blood Cancer J 2015; 5:e338 Epub 2015 Aug 14
    View PubMed
  30. Siontis B , Kumar S , Dispenzieri A , Drake MT , Lacy MQ , Buadi F , Dingli D , Kapoor P , Gonsalves W , Gertz MA , Rajkumar SV . Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy. Blood Cancer J 2015; 5:e364 Epub 2015 Oct 23
    View PubMed
  31. Zand L, Nasr SH, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Kumar S, Kyle RA, Fervenza FC, Sethi S, Dingli D, Rajkumar SV, Kapoor P, McCurdy A, Leung N. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both. Leuk Lymphoma 2015; 56 (12):3357-64 Epub 2015 May 12
    View PubMed
  32. Vallumsetla N, Paludo J, Kapoor P. Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes. Ther Clin Risk Manag 2015; 11:1663-74 Epub 2015 Nov 06
    View PubMed
  33. Kourelis TV, Kumar SK, Go RS, Kapoor P, Kyle RA, Buadi FK, Gertz MA, Lacy MQ, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Zeldenrust SR, Rajkumar SV, Dispenzieri A. Immunoglobulin light chain amyloidosis is diagnosed late in patients with preexisting plasma cell dyscrasias. Am J Hematol. 2014 Nov; 89(11):1051-4. Epub 2014 Sep 02.
    View PubMed
  34. Gonsalves WI, Morice WG, Rajkumar V, Gupta V, Timm MM, Dispenzieri A, Buadi FK, Lacy MQ, Singh PP, Kapoor P, Gertz MA, Kumar SK. Quantification of clonal circulating plasma cells in relapsed multiple myeloma. Br J Haematol. 2014 Nov; 167(4):500-5. Epub 2014 Aug 12.
    View PubMed
  35. Gonsalves WI, Rajkumar SV, Gupta V, Morice WG, Timm MM, Singh PP, Dispenzieri A, Buadi FK, Lacy MQ, Kapoor P, Gertz MA, Kumar SK. Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma. Leukemia. 2014 Oct; 28(10):2060-5. Epub 2014 Mar 12.
    View PubMed
  36. Paludo J, Kapoor P, Oliveira JL, Garrity JA, Nowakowski GS. Mantle cell lymphoma: a great masquerader. Int J Hematol. 2014 Oct; 100(4):313-4. Epub 2014 Jul 30.
    View PubMed
  37. Gonsalves WI , Rajkumar SV , Go RS , Dispenzieri A , Gupta V , Singh PP , Buadi FK , Lacy MQ , Kapoor P , Dingli D , Lust JA , Zeldenrust SR , Hayman SR , Kyle RA , Gertz MA , Kumar SK . Trends in survival of patients with primary plasma cell leukemia: a population-based analysis. Blood 2014 Aug 7; 124 (6):907-12 Epub 2014 June 23
    View PubMed
  38. Glavey SV, Gertz MA, Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Kapoor P, Dingli D, McCurdy A, Hogan WJ, Gastineau DA, Leung N. Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT. Bone Marrow Transplant. 2014 Jul; 49(7):996.
    View PubMed
  39. Warsame R, Bang SM, Kumar SK, Gertz MA, Lacy MQ, Buadi F, Dingli D, Hayman SR, Kapoor P, Kyle RA, Leung N, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, Rajkumar SV, Dispenzieri A. Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant. Eur J Haematol. 2014 Jun; 92(6):485-90. Epub 2014 Mar 2
    View PubMed
  40. Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 2014 May; 28(5):1122-8. Epub 2013 Oct 25.
    View PubMed
  41. Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014 Apr; 89(4):484-92. Epub 2014 Feb 26.
    View PubMed
  42. Kourelis TV, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust SR, Leung N, Kyle RA, Russell SJ, Dingli D, Lust JA, Lin Y, Kapoor P, Go R, Rajkumar SV, Dispenzieri A. Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy. Am J Hematol. 2014 Mar; 89(3):302-5. Epub 2014 Feb 18.
    View PubMed
  43. Glavey SV, Gertz MA, Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Kapoor P, Dingli D, McCurdy A, Hogan WJ, Gastineau DA, Leung N. Erratum: Long-term outcome of patients with multiple myeloma-related advanced renal failure following auto-SCT (Bone Marrow Transplantation (2014) 49 (996) DOI:10.1038/bmt.2014.24). Bone Marrow Transplant. 2014; 49(7):996.
  44. Kapoor P, Kumar SK, Dispenzieri A, Lacy MQ, Buadi F, Dingli D, Russell SJ, Hayman SR, Witzig TE, Lust JA, Leung N, Lin Y, Zeldenrust SR, McCurdy A, Greipp PR, Kyle RA, Rajkumar SV, Gertz MA. Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. J Clin Oncol. 2013 Dec 20; 31(36):4529-35. Epub 2013 Nov 18.
    View PubMed
  45. Dispenzieri A, Stewart AK, Chanan-Khan A, Rajkumar SV, Kyle RA, Fonseca R, Kapoor P, Bergsagel PL, McCurdy A, Gertz MA, Lacy MQ, Lust JA, Russell SJ, Zeldenrust SR, Reeder C, Roy V, Buadi F, Dingli D, Hayman SR, Leung N, Lin Y, Mikhael J, Kumar SK. Smoldering multiple myeloma requiring treatment: time for a new definition? Blood. 2013 Dec 19; 122(26):4172-81. Epub 2013 Oct 21.
    View PubMed
  46. Kourelis TV , Kumar SK , Gertz MA , Lacy MQ , Buadi FK , Hayman SR , Zeldenrust S , Leung N , Kyle RA , Russell S , Dingli D , Lust JA , Lin Y, Lin Y, Kapoor P , Rajkumar SV, Rajkumar SV, McCurdy A , Dispenzieri A . Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis. J Clin Oncol 2013 Dec 1; 31 (34):4319-24 Epub 2013 Oct 21
    View PubMed
  47. Srivastava G, Rana V, Lacy MQ, Buadi FK, Hayman SR, Dispenzieri A, Gertz MA, Dingli D, Zeldenrust S, Russell S, McCurdy A, Kapoor P, Kyle R, Rajkumar SV, Kumar S. Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma. Leukemia. 2013 Oct; 27(10):2062-6. Epub 2013 May 07.
    View PubMed
  48. Gonsalves WI, Gertz MA, Dispenzieri A, Lacy MQ, Lin Y, Singh PP, Gupta V, Hayman SR, Buadi FK, Dingli D, Kapoor P, McCurdy AR, Kumar SK. Implications of continued response after autologous stem cell transplantation for multiple myeloma. Blood. 2013 Sep 5; 122(10):1746-9. Epub 2013 Jul 17.
    View PubMed
  49. Humeniuk MS, Gertz MA, Lacy MQ, Kyle RA, Witzig TE, Kumar SK, Kapoor P, Lust JA, Hayman SR, Buadi FK, Rajkumar SV, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, Dispenzieri A. Outcomes of patients with POEMS syndrome treated initially with radiation. Blood. 2013 Jul 4; 122(1):68-73. Epub 2013 May 22.
    View PubMed
  50. Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, Leung N, Dingli D, Dispenzieri A. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol. 2013 May; 88(5):375-8. Epub 2013 Mar 19.
    View PubMed
  51. Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, Leung N, Drake MT, Kapoor P, Ansell SM, Witzig TE, Lust JA, Dalton RJ, Gertz MA, Stewart AK, Rajkumar SV, Chanan-Khan A, Lacy MQ, Mayo Clinic. Rajkumar SV, Chanan-Khan A, Lacy MQ, Mayo Clinic. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc. 2013 Apr; 88(4):360-76.
    View PubMed
  52. Kapoor P, Ramakrishnan V, Rajkumar SV. Bortezomib combination therapy in multiple myeloma. Semin Hematol. 2012 Jul; 49(3):228-42.
    View PubMed
  53. Kapoor P, Thenappan T, Singh E, Kumar S, Greipp PR. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med. 2011 Nov; 124(11):1006-15.
    View PubMed
  54. Kapoor P, Rajkumar SV. Update on risk stratification and treatment of newly diagnosed multiple myeloma. Int J Hematol. 2011 Oct; 94(4):310-20. Epub 2011 Oct 18.
    View PubMed
  55. Kapoor P, Rajkumar SV, Dispenzieri A, Gertz MA, Lacy MQ, Dingli D, Mikhael JR, Roy V, Kyle RA, Greipp PR, Kumar S, Mandrekar SJ. Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis. Leukemia. 2011 Apr; 25(4):689-96. Epub 2011 Jan 14.
    View PubMed
  56. Kapoor P, Greipp PT, Schaefer EW, Mandrekar SJ, Kamal AH, Gonzalez-Paz NC, Kumar S, Greipp PR. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience. Mayo Clin Proc. 2010 Oct; 85(10):905-12. Epub 2010 Jul 15.
    View PubMed
  57. Kapoor P, Fonseca R, Rajkumar SV, Sinha S, Gertz MA, Stewart AK, Bergsagel PL, Lacy MQ, Dingli DD, Ketterling RP, Buadi F, Kyle RA, Witzig TE, Greipp PR, Dispenzieri A, Kumar S. Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. Mayo Clin Proc. 2010 Jun; 85(6):532-7.
    View PubMed
  58. Sadek I, Kapoor P, Gertz MA, Kumar S. An unusual neurological complication of light chain amyloidosis. Br J Haematol. 2010 Mar; 148(6):816. Epub 2009 Sep 16.
    View PubMed
  59. Parikh S, Shah R, Kapoor P. Portal vein thrombosis. Am J Med. 2010 Feb; 123(2):111-9.
    View PubMed
  60. Kapoor P, Kumar S, Fonseca R, Lacy MQ, Witzig TE, Hayman SR, Dispenzieri A, Buadi F, Bergsagel PL, Gertz MA, Dalton RJ, Mikhael JR, Dingli D, Reeder CB, Lust JA, Russell SJ, Roy V, Zeldenrust SR, Stewart AK, Kyle RA, Greipp PR, Rajkumar SV. Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone. Blood. 2009 Jul 16; 114(3):518-21. Epub 2009 Mar 26.
    View PubMed
  61. Kapoor P, Greipp PT, Morice WG, Rajkumar SV, Witzig TE, Greipp PR. Anti-CD20 monoclonal antibody therapy in multiple myeloma. Br J Haematol. 2008 Apr; 141(2):135-48. Epub 2008 Mar 03.
    View PubMed
  62. Chandrashekaran S, Parikh S, Kapoor P, Subbarayan S. Postpartum reversible cerebral vasoconstriction syndrome. Am J Med Sci. 2007 Sep; 334(3):222-4.
    View PubMed
  63. Kapoor P, Singh E, Radhakrishnan P, Mehta P. Splenectomy in plasma cell dyscrasias: a review of the clinical practice. Am J Hematol. 2006 Dec; 81(12):946-54.
    View PubMed